Minghuan Jiang

1.5k total citations
61 papers, 1.1k citations indexed

About

Minghuan Jiang is a scholar working on Epidemiology, Economics and Econometrics and Applied Microbiology and Biotechnology. According to data from OpenAlex, Minghuan Jiang has authored 61 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Epidemiology, 19 papers in Economics and Econometrics and 17 papers in Applied Microbiology and Biotechnology. Recurrent topics in Minghuan Jiang's work include Antibiotic Use and Resistance (17 papers), Pharmaceutical Economics and Policy (15 papers) and Influenza Virus Research Studies (13 papers). Minghuan Jiang is often cited by papers focused on Antibiotic Use and Resistance (17 papers), Pharmaceutical Economics and Policy (15 papers) and Influenza Virus Research Studies (13 papers). Minghuan Jiang collaborates with scholars based in China, Pakistan and United States. Minghuan Jiang's co-authors include Yu Fang, Joyce H. S. You, Shimin Yang, Jie Chang, Bing Lv, Kangkang Yan, Mingyue Zhao, Caijun Yang, Shan Zhu and Xiao Wang and has published in prestigious journals such as PLoS ONE, American Journal of Preventive Medicine and International Journal of Environmental Research and Public Health.

In The Last Decade

Minghuan Jiang

58 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Minghuan Jiang China 19 392 311 234 227 179 61 1.1k
Joseph Fadare Nigeria 18 436 1.1× 216 0.7× 235 1.0× 280 1.2× 244 1.4× 96 1.3k
Luwen Shi China 20 131 0.3× 318 1.0× 152 0.6× 111 0.5× 185 1.0× 106 1.3k
Khezar Hayat Pakistan 20 464 1.2× 210 0.7× 263 1.1× 305 1.3× 213 1.2× 72 1.2k
Jie Chang China 20 715 1.8× 135 0.4× 401 1.7× 331 1.5× 210 1.2× 84 1.3k
Alian A. Alrasheedy Saudi Arabia 23 363 0.9× 426 1.4× 209 0.9× 347 1.5× 244 1.4× 76 1.4k
Amanj Kurdi United Kingdom 26 833 2.1× 242 0.8× 389 1.7× 284 1.3× 435 2.4× 137 1.8k
Gebremedhin Beedemariam Gebretekle Ethiopia 18 248 0.6× 191 0.6× 232 1.0× 138 0.6× 211 1.2× 55 911
Dan Kibuule Namibia 17 301 0.8× 183 0.6× 183 0.8× 128 0.6× 187 1.0× 69 838
Teferi Gedif Fenta Ethiopia 18 153 0.4× 146 0.5× 161 0.7× 83 0.4× 173 1.0× 73 804
Isha Patel United States 16 241 0.6× 135 0.4× 116 0.5× 237 1.0× 184 1.0× 77 998

Countries citing papers authored by Minghuan Jiang

Since Specialization
Citations

This map shows the geographic impact of Minghuan Jiang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Minghuan Jiang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Minghuan Jiang more than expected).

Fields of papers citing papers by Minghuan Jiang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Minghuan Jiang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Minghuan Jiang. The network helps show where Minghuan Jiang may publish in the future.

Co-authorship network of co-authors of Minghuan Jiang

This figure shows the co-authorship network connecting the top 25 collaborators of Minghuan Jiang. A scholar is included among the top collaborators of Minghuan Jiang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Minghuan Jiang. Minghuan Jiang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Saeed, Amna, Sundus Shukar, Caijun Yang, et al.. (2025). Pakistan’s first medicine price deregulation policy: assessing its impact on prices, affordability, and availability of oral anti-diabetic medicines in private pharmacies. Frontiers in Pharmacology. 16. 1627735–1627735. 1 indexed citations
2.
Jin, Peng, Xinglong Zheng, Minghuan Jiang, et al.. (2025). Cost-Effectiveness of Aortic Valve Replacement in Low- and Intermediate-Risk Chinese Patients With Severe Aortic Stenosis. Circulation Cardiovascular Quality and Outcomes. 18(4). e010858–e010858. 1 indexed citations
3.
Atif, Naveel, Furqan Khurshid Hashmi, Usman Rashid Malik, et al.. (2025). From awareness to acceptance: understanding HPV and vaccine knowledge, attitudes and beliefs among university students in Punjab, Pakistan. Journal of Pharmaceutical Policy and Practice. 18(1). 2473023–2473023.
4.
5.
Ma, Yue, et al.. (2023). Access to anticancer medicines in public hospitals of Northwestern China. Frontiers in Public Health. 11. 1182617–1182617. 1 indexed citations
6.
Jin, Peng, et al.. (2023). Cost-Effectiveness and Health Impacts of Different Influenza Vaccination Strategies for Children in China. American Journal of Preventive Medicine. 65(1). 155–164. 3 indexed citations
7.
Kabba, John Alimamy, Xuelin Yao, Caijun Yang, et al.. (2022). Current situation and future development of the biopharmaceutical industry in China: A mixed-method study. Frontiers in Pharmacology. 13. 911165–911165. 4 indexed citations
8.
9.
Saeed, Amna, Hamid Saeed, Zikria Saleem, et al.. (2020). Impact of National Drug Pricing Policy 2018 on access to medicines in Lahore division, Pakistan: a pre-post survey study using WHO/HAI methodology. BMJ Open. 10(10). e034720–e034720. 7 indexed citations
10.
Yan, Kangkang, Caijun Yang, Hongli Zhang, et al.. (2020). Impact of the zero-mark-up drug policy on drug-related expenditures and use in public hospitals, 2016–2018: an interrupted time series study in Shaanxi. BMJ Open. 10(11). e037034–e037034. 14 indexed citations
11.
Hayat, Khezar, Meagen Rosenthal, Ali Hassan Gillani, et al.. (2020). Perspective of Key Healthcare Professionals on Antimicrobial Resistance and Stewardship Programs: A Multicenter Cross-Sectional Study From Pakistan. Frontiers in Pharmacology. 10. 1520–1520. 41 indexed citations
12.
13.
Jiang, Minghuan, et al.. (2019). Standing orders program of pneumococcal vaccination for hospitalized elderly patients in Hong Kong: A cost-effectiveness analysis. American Journal of Infection Control. 47(11). 1302–1308. 4 indexed citations
14.
15.
Wong, Carlos King Ho, Minghuan Jiang, & Joyce H. S. You. (2016). Potential Cost-Effectiveness of an Influenza Vaccination Program Offering Microneedle Patch for Vaccine Delivery in Children. PLoS ONE. 11(12). e0169030–e0169030. 16 indexed citations
16.
Chang, Jie, Dan Ye, Bing Lv, et al.. (2016). Sale of antibiotics without a prescription at community pharmacies in urban China: a multicentre cross-sectional survey. Journal of Antimicrobial Chemotherapy. 72(4). dkw519–dkw519. 108 indexed citations
17.
Jiang, Minghuan & Joyce H. S. You. (2015). CYP2C19 genotype plus platelet reactivity-guided antiplatelet therapy in acute coronary syndrome patients. Pharmacogenetics and Genomics. 25(12). 609–617. 15 indexed citations
18.
Jiang, Minghuan, Zhongliang Zhou, Qian Shen, et al.. (2014). Medicine prices, availability, and affordability in the Shaanxi Province in China: implications for the future. International Journal of Clinical Pharmacy. 37(1). 12–17. 19 indexed citations
19.
Jiang, Minghuan. (2013). Comparative Study on the Price and Availability of Essential Drugs in Public Hospital and Retail Pharmacy of Shaanxi Province. Zhongguo yaofang. 2 indexed citations
20.
Fang, Yu, Anita K. Wagner, Shimin Yang, et al.. (2013). Access to affordable medicines after health reform: evidence from two cross-sectional surveys in Shaanxi Province, western China. The Lancet Global Health. 1(4). e227–e237. 67 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Joseph Fadare Breakdown of academic impact, for papers by Luwen Shi Breakdown of academic impact, for papers by Khezar Hayat Breakdown of academic impact, for papers by Jie Chang Breakdown of academic impact, for papers by Alian A. Alrasheedy Breakdown of academic impact, for papers by Amanj Kurdi Breakdown of academic impact, for papers by Gebremedhin Beedemariam Gebretekle Breakdown of academic impact, for papers by Dan Kibuule Breakdown of academic impact, for papers by Teferi Gedif Fenta Breakdown of academic impact, for papers by Isha Patel
Rankless by CCL
2026